MedPath

Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort

Completed
Conditions
Metabolic Syndrome
Type 2 Diabetes Mellitus
Interventions
Device: Diffuse Optical Spectroscopy
Registration Number
NCT00786721
Lead Sponsor
University of California, Irvine
Brief Summary

There has been increasing support for our hypothesis that mitochondrial dysfunction plays an important role in the etiology of Type 2 Diabetes Mellitus and the overlapping Metabolic Syndrome.

Detailed Description

Once the mitochondrial defect(s) of these subjects has been defined, the data will be used to develop two non-invasive screening tools to detect mitochondrial defects in Diabetes Mellitus and Metabolic Syndrome patients.

The device call Diffuse Optical Spectroscopy develope at Beckman Laser Instituteis is non-invasive measurement technique, to measure the properties of the muscle tisuue and vascular activity (calf, bicep, or the brain)to evaluate the patient's metabolic status and and to assess muscle mitochondrial OXPHOS function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Chinese descent and have been clinically diagnosed with diabetes mellitus (DM) or have met the study criteria for metabolic syndrome (MS).
Exclusion Criteria
  • non chiness descent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Diffuse Optical SpectroscopyDiffuse Optical Spectroscopymuscle properties scanning
Primary Outcome Measures
NameTimeMethod
Near Infrared Spectroscopy to assess muscle mitochondrial OXPHOS function.4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beckman Laser Institute Medical clinic

🇺🇸

Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath